These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31015127)

  • 1. Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancer.
    Hiroshima Y; Fukumitsu N; Saito T; Numajiri H; Murofushi KN; Ohnishi K; Nonaka T; Ishikawa H; Okumura T; Sakurai H
    Radiother Oncol; 2019 Jul; 136():37-43. PubMed ID: 31015127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study.
    Choi Y; Oh DY; Kim K; Chie EK; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Ha SW; Bang YJ
    Cancer Res Treat; 2016 Jul; 48(3):1045-55. PubMed ID: 26511805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity modulated radiotherapy for locally advanced and metastatic pancreatic cancer: a mono-institutional retrospective analysis.
    Wang Z; Ren ZG; Ma NY; Zhao JD; Zhang Z; Ma XJ; Long J; Xu J; Jiang GL
    Radiat Oncol; 2015 Jan; 10():14. PubMed ID: 25575617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent radiotherapy and gemcitabine for unresectable pancreatic adenocarcinoma: impact of adjuvant chemotherapy on survival.
    Ogawa K; Ito Y; Hirokawa N; Shibuya K; Kokubo M; Ogo E; Shibuya H; Saito T; Onishi H; Karasawa K; Nemoto K; Nishimura Y;
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):559-65. PubMed ID: 22019243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients.
    Mattiucci GC; Boldrini L; Nardangeli A; D'Aviero A; Buwenge M; Cellini F; Deodato F; Dinapoli N; Frascino V; Macchia G; Morganti AG; Valentini V
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):661-667. PubMed ID: 33001271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of proton beam radiotherapy and hyper-fractionated accelerated chemoradiotherapy for locally advanced pancreatic cancer.
    Maemura K; Mataki Y; Kurahara H; Kawasaki Y; Iino S; Sakoda M; Ueno S; Arimura T; Higashi R; Yoshiura T; Shinchi H; Natsugoe S
    Pancreatology; 2017; 17(5):833-838. PubMed ID: 28778480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.
    Chang JY; Verma V; Li M; Zhang W; Komaki R; Lu C; Allen PK; Liao Z; Welsh J; Lin SH; Gomez D; Jeter M; O'Reilly M; Zhu RX; Zhang X; Li H; Mohan R; Heymach JV; Vaporciyan AA; Hahn S; Cox JD
    JAMA Oncol; 2017 Aug; 3(8):e172032. PubMed ID: 28727865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
    Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F
    BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with long-term survival in gemcitabine-concurrent proton radiotherapy for non-metastatic locally advanced pancreatic cancer: a single-center retrospective study.
    Ogura Y; Terashima K; Nanno Y; Park S; Suga M; Takahashi D; Matsuo Y; Sulaiman NS; Tokumaru S; Okimoto T; Toyama H; Fukumoto T
    Radiat Oncol; 2022 Feb; 17(1):32. PubMed ID: 35144647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Concurrent chemoradiotherapy followed by consolidation chemotherapy and sequential chemoradiotherapy for stage III non-small cell lung cancer: comparison in 93 patients].
    Sun WZ; Song LP; Zhang YB; Ai T; Lu JL; Ren J; Gao Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):362-7. PubMed ID: 22445984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in carbohydrate antigen 19-9 level as a prognostic marker of overall survival in locally advanced pancreatic cancer treated with concurrent chemoradiotherapy.
    Kim YJ; Koh HK; Chie EK; Oh DY; Bang YJ; Nam EM; Kim K
    Int J Clin Oncol; 2017 Dec; 22(6):1069-1075. PubMed ID: 28477059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Outcomes of Proton Beam Therapy for Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Retrospective Study.
    Seto I; Yamaguchi H; Takagawa Y; Azami Y; Takayama K; Suzuki M; Machida M; Dai Y; Sulaiman NSB; Kikuchi Y; Kato T; Nishino N; Teranishi Y; Murakami M
    Adv Radiat Oncol; 2024 Oct; 9(10):101577. PubMed ID: 39309704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of gemcitabine for locally advanced pancreatic cancer: comparison with 5-fluorouracil-based chemoradiotherapy.
    Tada M; Arizumi T; Nakai Y; Sasaki T; Kogure H; Togawa O; Matsubara S; Tsujino T; Hirano K; Sasahira N; Isayama H; Kawabe T; Omata M
    Chemotherapy; 2008; 54(4):302-8. PubMed ID: 18689983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis.
    Terashima K; Demizu Y; Hashimoto N; Jin D; Mima M; Fujii O; Niwa Y; Takatori K; Kitajima N; Sirakawa S; Yonson K; Hishikawa Y; Abe M; Sasaki R; Sugimura K; Murakami M
    Radiother Oncol; 2012 Apr; 103(1):25-31. PubMed ID: 22300608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and Safety of Simultaneous Integrated Boost-Proton Beam Therapy for Localized Pancreatic Cancer.
    Kim TH; Lee WJ; Woo SM; Kim H; Oh ES; Lee JH; Han SS; Park SJ; Suh YG; Moon SH; Kim SS; Kim DY
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818783879. PubMed ID: 29962281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Full-dose gemcitabine is a more effective chemotherapeutic agent than 5-fluorouracil for concurrent chemoradiotherapy as first-line treatment in locally advanced pancreatic cancer.
    Kang H; Chang JS; Oh TG; Chung MJ; Park JY; Park SW; Seong J; Song SY; Chung JB; Bang S
    Chemotherapy; 2014; 60(3):191-9. PubMed ID: 25824121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton beam therapy for unresectable intrahepatic cholangiocarcinoma.
    Ohkawa A; Mizumoto M; Ishikawa H; Abei M; Fukuda K; Hashimoto T; Sakae T; Tsuboi K; Okumura T; Sakurai H
    J Gastroenterol Hepatol; 2015 May; 30(5):957-63. PubMed ID: 25376272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment results of alternating chemoradiotherapy followed by proton beam therapy boost combined with intra-arterial infusion chemotherapy for stage III-IVB tongue cancer.
    Takayama K; Nakamura T; Takada A; Makita C; Suzuki M; Azami Y; Kato T; Hayashi Y; Ono T; Toyomasu Y; Hareyama M; Kikuchi Y; Daimon T; Mitsudo K; Tohnai I; Fuwa N
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):659-67. PubMed ID: 26521257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Consolidation Chemoradiotherapy in Locally Advanced Pancreatic Cancer Receiving Chemotherapy: An Updated Systematic Review and Meta-Analysis.
    Chang JS; Chiu YF; Yu JC; Chen LT; Ch'ang HJ
    Cancer Res Treat; 2018 Apr; 50(2):562-574. PubMed ID: 28602054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer.
    Kelly P; Das P; Pinnix CC; Beddar S; Briere T; Pham M; Krishnan S; Delclos ME; Crane CH
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e143-9. PubMed ID: 23200173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.